Ceribell (CBLL) Long-Term Debt Issuances (2024)
Ceribell (CBLL) reported Long-Term Debt Issuances of $7.9 million for Q1 2024.
Ceribell (CBLL) Long-Term Debt Issuances (2024) Analysis & Trends
Ceribell has reported Long-Term Debt Issuances for 1 years, with the latest figure at $7.9 million in Q1 2024.
- For the quarter ending Q1 2024, Long-Term Debt Issuances changed N/A year-over-year to $7.9 million; the trailing twelve-month figure through Dec 2024 stood at $7.9 million (changed N/A YoY), and the FY2024 full-year result was $7.9 million, changed N/A from the prior year.
- Long-Term Debt Issuances for Q1 2024 stood at $7.9 million.
- The five-year high for Long-Term Debt Issuances was $7.9 million in Q1 2024, with the low at $7.9 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 1.15 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.71 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Ceribell | 695.83 Mn | 554.65 Mn | 23.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 7.91 Mn |
| Mar 31, 2024 | 7.91 Mn |